Structural basis for high-affinity HER2 receptor binding by an engineered protein
about
Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imagingProgrammable polyproteams built using twin peptide supergluesEngineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albuminCrystal structure of LGR4-Rspo1 complex: insights into the divergent mechanisms of ligand recognition by leucine-rich repeat G-protein-coupled receptors (LGRs).Genomic analysis of the ecdysone steroid signal at metamorphosis onset using ecdysoneless and EcRnull Drosophila melanogaster mutants.Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substratePET of HER2 Expression with a Novel 18FAl Labeled Affibody.Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumorStructural insights for engineering binding proteins based on non-antibody scaffoldsThe HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cells.Improvement of mass spectrometry analysis of glycoproteins by MALDI-MS using 3-aminoquinoline/α-cyano-4-hydroxycinnamic acid.Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive TumorsHER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery.68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PETLocal variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopyA Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold.Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitroScratching the Surface: Resurfacing Proteins to Endow New Properties and Function.Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.SpyLigase peptide-peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture.Antibody fragments as tools in crystallography.Design and evaluation of radiolabeled tracers for tumor imaging.A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays.Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers.Genetically encoding new bioreactivity.Receptor-directed chimeric toxins created by sortase-mediated protein fusion.Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.Genetically encoding an electrophilic amino acid for protein stapling and covalent binding to native receptors.Surface charge tuneable fluorescent protein-based logic gates for smart delivery of nucleic acids.Nanobodies: Chemical Functionalization Strategies and Intracellular Applications.Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodies.Current Conjugation Methods for Immunosensors.Affibody conjugation onto bacterial cellulose tubes and bioseparation of human serum albuminThe architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers
P2860
Q27333491-3BD900FD-6105-4D7A-BE54-89042218B9DFQ28272295-7B9AAC85-AA70-473F-A742-876DA40D692DQ28541561-D9035D40-623F-4324-90C4-9E322348BDC9Q30369442-4D36F2C5-8A80-49C1-A167-4D04E03E1D42Q30536951-ADE05359-8D4C-43CF-8C27-F440563A706AQ33685019-8C03D2F5-956D-4421-A7CD-6126A5FE70B1Q33776692-286629B3-BC53-4255-9B02-49B93EA1ED0AQ33841547-8A06E374-9DBB-49DA-A3B6-94BE75A29D3CQ34134371-A0A63694-0F2E-45EA-A1ED-09CE3E22B60CQ34322939-8EE1BBFF-093C-48CE-9144-D2D507DC9E72Q34482547-FA625FFF-07E0-409B-A874-F5D49A984519Q34574191-4DC1639B-A6E6-4FFA-AE6F-9139BB0C2521Q35484964-A13B8967-D2EE-4F21-9052-F82A1A9633F8Q35942583-8AF1A714-CADD-40D1-AD1D-9EEB1A5D5DC7Q36046167-622E9ACD-4E2D-4468-9D02-ADE283934D5DQ36085489-95A55349-E137-4A9A-A3DF-2E3D1F00F376Q36284765-DF778BD4-C5AB-46DA-A5E4-EF49322BD766Q36293727-56B180E3-1E1E-4B8F-AB59-8D68113AB757Q36510875-C47FDA58-9F08-42CA-98A5-EF6B023959BDQ36641436-F765F4D8-5747-4C01-A4F3-4B695D9444FEQ36945870-9298D4B4-4D71-4C80-8B2F-2964C9E7927EQ37634520-952F5F51-2E0A-4186-9F69-2C278F908DD5Q37687557-43E679CA-AE26-4565-84A1-E95D5396D4D4Q37886029-EFD75F65-95EF-4F18-8E55-AD1F916EAB02Q38137253-EA8D672C-05C4-4896-9139-917C98FCB4A1Q38642011-8E0C59A4-20AF-448B-9A49-A1C053F9687EQ38695293-73DF28C8-1778-4F93-B729-2098430ECF79Q38976621-3B04FEA1-E3EB-4D52-9ED4-DC4E877D577BQ39110294-2822403A-5AFB-41CE-821E-40BD2857E761Q41083360-FDC65ED7-715E-43AD-B30F-63E4185A4776Q42906279-7511E3EB-BF62-4665-AF71-5747D2ED2B3EQ47612068-781BFE6C-6B33-4198-9C2E-EB2FD3782F77Q47797367-928DA062-ECF1-4CB8-9B27-C1D7B7D27D52Q47996245-3AEC3B02-A527-47B5-8DC6-EC8C3C76E7DAQ51028189-02459DF4-B811-40F5-8460-A72F86AF5737Q52559226-8C1C48B6-3935-4FF4-AB90-4A40884F8198Q57423743-2172647C-D39B-4F43-93E9-3B96FFA236ECQ58600328-3E1D5558-A88A-4F92-8098-E0CCD46247C4
P2860
Structural basis for high-affinity HER2 receptor binding by an engineered protein
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@ast
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@en
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@nl
type
label
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@ast
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@en
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@nl
prefLabel
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@ast
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@en
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@nl
P2860
P50
P3181
P356
P1476
Structural basis for high-affinity HER2 receptor binding by an engineered protein
@en
P2093
Lars Abrahmsén
P2860
P304
P3181
P356
10.1073/PNAS.1005025107
P407
P577
2010-08-24T00:00:00Z